More research is needed to establish the benefit-risk profile of curcumin

Int J Cancer. 2011 Jan 1;128(1):245-6. doi: 10.1002/ijc.25291.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / therapeutic use
  • Apoptosis / drug effects
  • Curcumin / adverse effects
  • Curcumin / metabolism*
  • Curcumin / therapeutic use
  • DNA / metabolism*
  • Electrophoresis, Agar Gel
  • Humans
  • Intercalating Agents / adverse effects
  • Intercalating Agents / metabolism
  • Intercalating Agents / therapeutic use
  • Neoplasms / drug therapy
  • Neoplasms / pathology

Substances

  • Antineoplastic Agents
  • Intercalating Agents
  • DNA
  • Curcumin